 Cancer TypeCondition: Skin cancer, melanomaStageSubtype: stage I melanomaTrial Type: TreatmentStatus: Not yet activePhase: Phase IIType: TreatmentAge: 18 and overTrial IDs: S1512, NCI-2016-00666, NCT02775851 